Effect of Ondansetron for Withdrawal Symptoms
Completed · Not applicable · Has a placebo group
Conditions studied: Substance Withdrawal Syndrome
In brief
We hope to determine whether Ondansetron, an anti-nausea medication, works to help relieve withdrawal symptoms experienced while the patient is being weaned off opioid medications. This medication has shown anecdotal evidence of being affective for the treatment of withdrawal symptoms and we hope to determine whether this is affective.
Key facts
- Study ID
- NCT00695864
- Run by
- Stanford University
- People needed
- 31
- Starts
- 2008-05-01
- Expected to finish
- 2009-07-01
- Last updated by the study team
- 2017-05-15
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Stanford University School of Medicine — Stanford, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.